Rigel Pharmaceuticals
South San Francisco, US · Founded 1996 · 290 employees on LinkedIn · 2 known investors
Rigel is a biopharmaceutical company that develops and markets therapies including olutasidenib, pralsetinib, and fostamatinib for conditions such as acute myeloid leukemia and chronic immune thrombocytopenia. This page invites investigator-sponsored research proposals, offering study drug and/or monetary grants for independent studies aligned with Rigel's therapeutic areas.
Founders & leadership
RR
Raul Rodriguezin
Investors · 2
Competitors · 4
by search overlap
Robinhood44 shared keywordsRobinhood is a financial trading platform that enables users to manage portfolios across stocks, ETFs, cryptocurrencies, options, futures, and prediction markets. The platform serves retail investors with low barriers to entry, offering portfolio management services and market insights.
Seeking Alpha42 shared keywordsSeeking Alpha is a financial research platform offering stock analysis, market news, investment ideas, and quantitative ratings across asset classes, drawing on a large community of contributing analysts. It serves individual and professional investors seeking research and data-driven insight on stocks and markets.
StockTwits31 shared keywordsStocktwits is a social platform for investors and traders to share market news, discussions, sentiment polls, and live financial content. It aggregates breaking market news, equity coverage, and community discussions around individual stocks and crypto.
TradingView30 shared keywordsTradingView is a charting platform and social network used by over 100 million traders and investors worldwide to analyze and trade across global financial markets. The platform provides tools for technical analysis, market data, and community collaboration for retail and institutional traders.
Companies competing with Rigel Pharmaceuticals for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Rigel Pharmaceuticals do?
- Rigel is a biopharmaceutical company that develops and markets therapies including olutasidenib, pralsetinib, and fostamatinib for conditions such as acute myeloid leukemia and chronic immune thrombocytopenia. This page invites investigator-sponsored research proposals, offering study drug and/or monetary grants for independent studies aligned with Rigel's therapeutic areas.
- Who are Rigel Pharmaceuticals's investors?
- Rigel Pharmaceuticals's investors include Frazier Life Sciences, New Enterprise Associates (NEA).
- Where is Rigel Pharmaceuticals headquartered?
- Rigel Pharmaceuticals is headquartered in South San Francisco, US.